PEOPLE - Bio-Technology General (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Bio-Technology General (Iselin, New Jersey), a developer, manufacturer and marketer of genetically engineered and other products for healthcare, has appointed Christopher Clement as president and COO. Mr Clement, who most recently served as CEO and chairman at Epicyte Pharmaceutical, will replace Virgil Thompson, who vacated the position in 2000 but remains on the board.